Akèy › Maladie de Huntington
Etid klinik pou Maladie de Huntington ap rekrite nan Etazini
18 etid pou Maladie de Huntington ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX5 etid
- Baltimore, MD4 etid
- Nashville, TN4 etid
- Denver, CO4 etid
- Washington, DC4 etid
- New York City, NY4 etid
- Boston, MA4 etid
- Columbus, OH4 etid
- Durham, NC4 etid
- Rochester, NY4 etid
- Orlando, FL3 etid
- Cleveland, OH3 etid
- Wichita, KS3 etid
- Chicago, IL3 etid
- Seattle, WA3 etid
- Birmingham, AL3 etid
- Cincinnati, OH3 etid
- Sacramento, CA3 etid
- Portland, OR3 etid
- San Diego, CA3 etid
- Burlington, VT3 etid
- Philadelphia, PA3 etid
- Pittsburgh, PA3 etid
Pa eta
- Alabama3 etid
- Colorado4 etid
- Distrik Columbia4 etid
- Florid6 etid
- Illinois3 etid
- Kalifòni5 etid
- Kansas3 etid
- Maryland4 etid
- Massachusetts4 etid
- New York6 etid
- North Carolina4 etid
- Ohio5 etid
- Oregon3 etid
- Pennsylvania3 etid
- Tennessee4 etid
- Texas6 etid
- Vermont3 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Pridopidine Phase 3 Study in Huntington's Disease
Ap rekriteFaz 3
Laj 23 a 65 · Tout sèks · Mizajou Sep 30, 2026 · NCT07609108A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Ap rekriteFaz 3
Laj 21 a 70 · Tout sèks · Mizajou Sep 22, 2026 · NCT07326709Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
Ap rekriteFaz 2/3
Laj 25 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07378644Digital Measures for Clinical Trial Endpoints in Huntington's Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 25 a 65 · Tout sèks · Mizajou Aug 17, 2026 · NCT07010705A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
Ap rekriteFaz 1/2
Laj 25 a 65 · Tout sèks · Mizajou May 5, 2026 · NCT06826612HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 11 a 75 · Tout sèks · Mizajou Apr 27, 2026 · NCT02855476Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Apr 13, 2026 · NCT07451613Cognitive Assessment Tools for Huntington's Disease.
Ap rekriteEtid obsèvasyon
Laj 30 a 65 · Tout sèks · Mizajou Mar 2, 2026 · NCT06546488Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Disease
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Feb 11, 2026 · NCT05326451Home-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Feb 11, 2026 · NCT06843252Retinal Imaging in Neurodegenerative Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 4, 2026 · NCT03233646Longitudinal Endpoint Assessment of Disease Burden in HD
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2025 · NCT06475898Gut Microbiomes in HD
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2025 · NCT06448546Huntington's Disease Biobank: Advancing Remote Monitoring and Deep Phenotyping
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Apr 24, 2025 · NCT06941662University of Central Florida CereBank
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Fanm · Mizajou Mar 14, 2025 · NCT06876857NYSCF Scientific Discovery Biobank
Ap rekriteEtid obsèvasyon
30 Days · Tout sèks · Mizajou Mar 3, 2025 · NCT06203106Extracellular Vesicles for HD
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Dec 6, 2024 · NCT06082713Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 28, 2024 · NCT01574053Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.